Ipsen
is a France-based biopharmaceutical company that develops and commercializes generic medicines for the treatment of cancer and neurogenerative disease... Read moreIpsen
is a France-based biopharmaceutical company that develops and commercializes generic medicines for the treatment of cancer and neurogenerative disease... Read more
News
Partnership
Jan 30, 2026
Yahoo
Origami Therapeutics Announces Global Collaboration with Ipsen to Advance Protein Degrader Program
Acquisition
Oct 22, 2025
FinanzNachrichten
Ipsen acquired ImCheck Therapeutics SAS for $406.6M
Product Launch
Oct 20, 2025
Korea Biomedical Review
Ipsen's Bylvay launches in Korea with national coverage for a rare childhood liver disease
Funding
Mar 19, 2025
FinanzNachrichten
Ipsen received $546.4M in Post-IPO Debt Funding
Ipsen Competitors
1
2
3
4
5
6
7
8
9
10